Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.36 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.36 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.36 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.36 |
| ▸ | ITGAL | P20701 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31710559 | 0.88 | CYP1A2 (0.36) | CYP1A2CA1CA9CYP2D6CYP2C9 | |
| SCHEMBL9067300 | 0.86 | CYP1A2 (0.35) | CYP1A2CA1CA9CYP2D6CYP2C9 | |
| SCHEMBL3629961 | 0.82 | CYP1A2 (0.49) | CYP1A2CA1CA9MIF | |
| SCHEMBL10688261 | 0.82 | CYP1A2 (0.44) | CYP1A2CA1CA9ALDH1A1POLB | |
| SCHEMBL19547206 | 0.81 | CYP1A2 (0.41) | CYP1A2CA1CA9 | |
| SCHEMBL1114400 | 0.80 | CYP1A2 (0.51) | CYP1A2CA1CA9 | |
| SCHEMBL19313428 | 0.78 | CYP1A2 (0.36) | CYP1A2CYP2D6CYP2C9CYP2C19ITGB3 | |
| SCHEMBL8584608 | 0.77 | CYP1A2 (0.45) | CYP1A2CA1CA9MIF | |
| Oxalic Acid SCHEMBL28140423 | 0.76 | CYP1A2 (0.51) | CYP1A2CA1CA9CYP2D6CYP2C19 | |
| Methacrylic Acid SCHEMBL6282496 | 0.76 | CYP1A2 (0.41) | CYP1A2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306515-B1 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | TORAY INDUSTRIES (JP) | 2026-02-04 | — | — | EP | claimed |
| US-20240140927-A1 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | TORAY INDUSTRIES, INC. (JP) | 2024-05-02 | — | — | US | claimed |
| EP-4306515-A1 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | Toray Industries, Inc. (JP) | 2024-01-17 | — | — | EP | claimed |
| US-11760739-B2 | Method of producing 3-hydroxyadipic acid-3,6-lactone | TORAY INDUSTRIES, INC. (JP) | 2023-09-19 | — | — | US | claimed |
| CN-114806414-B | Silicon polishing composition, preparation method and application thereof | 万华化学集团电子材料有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-110023285-B | Process for producing epsilon-caprolactam | 东丽株式会社 | 2023-01-17 | — | — | CN | claimed |
| US-20220356140-A1 | METHOD FOR PRODUCING ADIPIC ACID | TORAY INDUSTRIES, INC. (JP) | 2022-11-10 | — | — | US | claimed |
| WO-2022191314-A1 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | 東レ株式会社 | 2022-09-15 | — | — | WO | claimed |
| CN-114806414-A | Silicon polishing composition, preparation method and application thereof | 万华化学集团电子材料有限公司 | 2022-07-29 | — | — | CN | claimed |
| EP-3553048-B1 | METHOD FOR PRODUCING EPSILON-CAPROLACTAM | TORAY INDUSTRIES (JP) | 2022-07-27 | — | — | EP | claimed |
| EP-3950680-A1 | METHOD FOR PRODUCING 3-HYDROXYADIPIC ACID-3,6-LACTONE | Toray Industries, Inc. (JP) | 2022-02-09 | — | — | EP | claimed |
| CN-113574052-A | Method for producing 3-hydroxyadipic acid-3, 6-lactone | 东丽株式会社 | 2021-10-29 | — | — | CN | claimed |
| US-11149001-B2 | Method for producing ϵ-caprolactam | TORAY INDUSTRIES, INC. (JP) | 2021-10-19 | — | — | US | claimed |
| WO-2020196459-A1 | METHOD FOR PRODUCING 3-HYDROXYADIPIC ACID-3,6-LACTONE | 東レ株式会社 | 2020-10-01 | — | — | WO | claimed |
| CN-107074761-B | Process for producing epsilon-caprolactam | 东丽株式会社 | 2020-04-14 | — | — | CN | claimed |
| US-20200062704-A1 | METHOD FOR PRODUCING epsilon-CAPROLACTAM | TORAY INDUSTRIES, INC. (JP) | 2020-02-27 | — | — | US | claimed |
| EP-3553048-A1 | METHOD FOR PRODUCING -CAPROLACTAM | Toray Industries, Inc. (JP) | 2019-10-16 | — | — | EP | claimed |
| US-10196352-B2 | Method for producing epsilon-caprolactam | TORAY INDUSTRIES, INC. (JP) | 2019-02-05 | — | — | US | claimed |
| US-20170320819-A1 | METHOD FOR PRODUCING EPSILON-CAPROLACTAM | TORAY INDUSTRIES, INC. (JP) | 2017-11-09 | — | — | US | claimed |
| EP-3214072-A1 | METHOD FOR PRODUCING -CAPROLACTAM | Toray Industries, Inc. (JP) | 2017-09-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320819-A1 | METHOD FOR PRODUCING EPSILON-CAPROLACTAM | HACL2, HM13, ALAD | CYP1A2 3054/4885CA1 679/4885CA9 431/4885 |
| US-20200062704-A1 | METHOD FOR PRODUCING epsilon-CAPROLACTAM | HAMP, NAAA, CAPN9 | CYP1A2 1573/4885CA1 1813/4885CA9 548/4885 |
| US-20220356140-A1 | METHOD FOR PRODUCING ADIPIC ACID | ADIPOR1, ACSL3, ADH7 | CYP1A2 2094/4885CA1 752/4885CA9 512/4885 |
| US-11149001-B2 | Method for producing ϵ-caprolactam | NAAA, HAMP, CAPN9 | CYP1A2 1297/4885CA1 1676/4885CA9 455/4885 |
| US-20240140927-A1 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | DHCR7, HSD3B1, HMGCR | CYP1A2 2039/4885CA1 886/4885CA9 374/4885 |
| US-10196352-B2 | Method for producing epsilon-caprolactam | HACL2, HM13, ALAD | CYP1A2 3054/4885CA1 679/4885CA9 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.